NEW CLINICAL TRIAL FOR #OSTEOSARCOMA ANNOUNCED!
MIB Agents Osteosarcoma Webinar Series: Katherine A. Janeway, MD, and Suzanne Forrest, MD discuss the opening of a new clinical trial for osteosarcoma, funded by Osteosarcoma Institute. Updates on the OSProject as well! TRIAL LINK
...
Guest Information:
*Katherine A. Janeway, MD, MMSc
Associate Professor of Pediatrics, HMX - Harvard Medical School
Senior Physician, Dana-Farber Cancer Institute/Boston Children's Hospitals Cancer & Blood Disorders Center
Director, Clinical Genomics, Dana-Farber Cancer Institute
*Suzanne Forrest, MD
Instructor of Pediatrics, Harvard Medical School Pediatric Hematology/Oncology,
Dana-Farber Cancer Institute, Boston Children's Cancer & Blood Disorders
...
All OsteoWarrior Panelists are;
*Maeve Smart
is an MIB Agents Jr. Board Member and and OsteoWarrior
*Alexis Johnson
is an MIB Agents Jr. Board Member and MIB Mission Commander
*Amanda Braunfeld Levine
is a Patient Advocate and Founder/Moderator of Osteosarcoma Support FaceBook Page
...
Hosted by Ann Graham, MIB Agents Founder & President.
…
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
...
Register for next week when Ellen Shobet, RN Nurse Navigator at Baylor College of Medicine
and Texas Children's Hospital
is here with David Poplack, MD, Director of Global Hematology-Oncology Pediatric Excellence (HOPE) and Associate Director of Texas Children’s Cancer and Hematology Centers to talk about Passport for Care. Register: https://bit.ly/MIBobites Less
